Alfavision Overseas (India) Limited (BOM:531156)
11.70
+0.46 (4.09%)
At close: Aug 21, 2026
BOM:531156 Revenue
Alfavision Overseas (India) had revenue of 5.76M INR in the quarter ending June 30, 2026, a decrease of -56.67%. This brings the company's revenue in the last twelve months to 12.37M, down -45.41% year-over-year. In the fiscal year ending March 31, 2026, Alfavision Overseas (India) had annual revenue of 19.91M with 4.44% growth.
Revenue (ttm)
12.37M
Revenue Growth
-45.41%
P/S Ratio
29.82
Revenue / Employee
1.37M
Employees
9
Market Cap
368.85M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 19.91M | 846.00K | 4.44% |
| Mar 31, 2025 | 19.06M | -12.21M | -39.05% |
| Mar 31, 2024 | 31.27M | -276.84M | -89.85% |
| Mar 31, 2023 | 308.11M | -1.51B | -83.03% |
| Mar 31, 2022 | 1.82B | 24.74M | 1.38% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Smruthi Organics | 1.12B |
| Kimia Biosciences | 1.12B |
| Tyche Industries | 500.33M |
| Vasundhara Rasayans | 347.79M |
| Crestchem | 338.33M |
| Link Pharma Chem | 283.85M |
| Krebs Biochemicals & Industries | 252.34M |